156 related articles for article (PubMed ID: 12954123)
21. A general, extracorporeal immunoadsorption method to increase the tumor-to-normal tissue ratio in radioimmunoimaging and radioimmunotherapy.
Norrgren K; Strand SE; Nilsson R; Lindgren L; Sjögren HO
J Nucl Med; 1993 Mar; 34(3):448-54. PubMed ID: 8441037
[TBL] [Abstract][Full Text] [Related]
22. In vitro evaluation of avidin antibody pretargeting using 211At-labeled and biotinylated poly-L-lysine as effector molecule.
Frost SH; Jensen H; Lindegren S
Cancer; 2010 Feb; 116(4 Suppl):1101-10. PubMed ID: 20127953
[TBL] [Abstract][Full Text] [Related]
23. Extracorporeal immunoadsorption compared to avidin chase: enhancement of tumor-to-normal tissue ratio for biotinylated rhenium-188-chimeric BR96.
Chen JQ; Strand SE; Tennvall J; Lindgren L; Hindorf C; Sjögren HO
J Nucl Med; 1997 Dec; 38(12):1934-9. PubMed ID: 9430473
[TBL] [Abstract][Full Text] [Related]
24. Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system.
Goodwin DA; Meares CF; Osen M
J Nucl Med; 1998 Oct; 39(10):1813-8. PubMed ID: 9776294
[TBL] [Abstract][Full Text] [Related]
25. Repeating the avidin "chase" markedly improved the biodistribution of radiolabelled biotinylated antibodies and promoted the excretion of additional background radioactivity.
Kobayashi H; Sakahara H; Endo K; Yao ZS; Toyama S; Konishi J
Eur J Cancer; 1995 Sep; 31A(10):1689-96. PubMed ID: 7488426
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and organ clearance of a 3'-biotinylated, internally [32P]-labeled phosphodiester oligodeoxynucleotide coupled to a neutral avidin/monoclonal antibody conjugate.
Kang YS; Boado RJ; Pardridge WM
Drug Metab Dispos; 1995 Jan; 23(1):55-9. PubMed ID: 7720525
[TBL] [Abstract][Full Text] [Related]
27. Biocompatibility of a novel avidin-agarose adsorbent for extracorporeal removal of redundant radiopharmaceutical from the blood.
Kurkus J; Nilsson R; Lindén O; Schönström N; Sandberg BE; Tennvall J
Artif Organs; 2007 Mar; 31(3):208-14. PubMed ID: 17343696
[TBL] [Abstract][Full Text] [Related]
28. Extracorporeal immunoadsorption from whole blood based on the avidin-biotin concept. Evaluation of a new method.
Garkavij M; Tennvall J; Strand SE; Nilsson R; Lindgren L; Chen J; Isaksson M; Eriksson H; Sjögren H
Acta Oncol; 1996; 35(3):309-12. PubMed ID: 8679261
[TBL] [Abstract][Full Text] [Related]
29. Enhanced radioimmunotargeting of 125I-labeled L6-biotin monoclonal antibody (MAb) by combining preload of cold L6 MAb and subsequent immunoadsorption in rats.
Garkavij M; Tennvall J; Strand SE; Norrgren K; Lindgren L; Nilsson R; Sjögren HO
Cancer Res; 1995 Dec; 55(23 Suppl):5874s-5880s. PubMed ID: 7493363
[TBL] [Abstract][Full Text] [Related]
30. Solid-phase biotinylation of antibodies.
Strachan E; Mallia AK; Cox JM; Antharavally B; Desai S; Sykaluk L; O'Sullivan V; Bell PA
J Mol Recognit; 2004; 17(3):268-76. PubMed ID: 15137036
[TBL] [Abstract][Full Text] [Related]
31. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model.
Sharkey RM; Karacay H; Griffiths GL; Behr TM; Blumenthal RD; Mattes MJ; Hansen HJ; Goldenberg DM
Bioconjug Chem; 1997; 8(4):595-604. PubMed ID: 9258460
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic modeling and absorbed dose estimation for chimeric anti-CEA antibody in humans.
Odom-Maryon TL; Williams LE; Chai A; Lopatin G; Liu A; Wong YC; Chou J; Clarke KG; Raubitschek AA
J Nucl Med; 1997 Dec; 38(12):1959-66. PubMed ID: 9430477
[TBL] [Abstract][Full Text] [Related]
33. The avidin-biotin complex (ABC) method and other avidin-biotin binding methods.
Bratthauer GL
Methods Mol Biol; 2010; 588():257-70. PubMed ID: 20012837
[TBL] [Abstract][Full Text] [Related]
34. Blood clearance of radiolabeled antibody: enhancement by lactosamination and treatment with biotin-avidin or anti-mouse IgG antibodies.
Klibanov AL; Martynov AV; Slinkin MA; Sakharov IYu ; Smirnov MD; Muzykantov VR; Danilov SM; Torchilin VP
J Nucl Med; 1988 Dec; 29(12):1951-6. PubMed ID: 2848113
[TBL] [Abstract][Full Text] [Related]
35. Targeting of vaccinia virus using biotin-avidin viral coating and biotinylated antibodies.
Purow B; Staveley-O'Carroll K
J Surg Res; 2005 Jan; 123(1):49-54. PubMed ID: 15652950
[TBL] [Abstract][Full Text] [Related]
36. Quantitative Correlation of in Vivo Properties with in Vitro Assay Results: The in Vitro Binding of a Biotin-DNA Analogue Modifier with Streptavidin Predicts the in Vivo Avidin-Induced Clearability of the Analogue-Modified Antibody.
Dou S; Virostko J; Greiner DL; Powers AC; Liu G
Mol Pharm; 2015 Aug; 12(8):3097-103. PubMed ID: 26103429
[TBL] [Abstract][Full Text] [Related]
37. Preoperative and intraoperative radioimmunodetection of cancer pretargeted by biotinylated monoclonal antibodies.
Di Carlo V; De Nardi P; Stella M; Magnani P; Fazio F
Semin Surg Oncol; 1998 Dec; 15(4):235-8. PubMed ID: 9829379
[TBL] [Abstract][Full Text] [Related]
38. The nonbiotinylated form of the 1.3 s subunit of transcarboxylase binds to avidin (monomeric)-agarose: purification and separation from the biotinylated 1.3 S subunit.
Shenoy BC; Magner WJ; Kumar GK; Phillips NF; Haase FC; Samols D
Protein Expr Purif; 1993 Feb; 4(1):85-94. PubMed ID: 8425112
[TBL] [Abstract][Full Text] [Related]
39. Avidin-biotin system: a small library of cysteine biotinylated derivatives designed for the [99mTc(N)(PNP)]2+ metal fragment.
Bolzati C; Caporale A; Agostini S; Carta D; Cavazza-Ceccato M; Refosco F; Tisato F; Schievano E; Bandoli G
Nucl Med Biol; 2007 Jul; 34(5):511-22. PubMed ID: 17591551
[TBL] [Abstract][Full Text] [Related]
40. Drug targeting to the brain using avidin-biotin technology in the mouse; (blood-brain barrier, monoclonal antibody, transferrin receptor, Alzheimer's disease).
Jeong Lee H; Pardridge WM
J Drug Target; 2000; 8(6):413-24. PubMed ID: 11328667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
